Skip to main content
SpringerLink
Log in

CQ50. Is Serum Thyroglobulin Measurement Useful as a Marker of Carcinoma Recurrence After Surgery?

  • Chapter
  • First Online:
Treatment of Thyroid Tumor

  • 1330 Accesses

Abstract

Thyroglobulin is a chief constituent of colloid in the thyroid follicles, which is vital for the synthesis of thyroid hormone. The serum thyroglobulin level of healthy people is around 30 ng/ml, but it decreases to nearly zero when thyroid tissue does not remain after total thyroidectomy. Whether thyroglobulin measurement is useful as a marker of recurrence after surgery for differentiated carcinoma is examined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Takami H (2005) (Text in Japanese) Gan to Kagakuryoho 32:561–565 (NR)

    Google Scholar 

  2. Hamy A, Mirallie E, Bennouna J et al (2004) Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer. Eur J Surg Oncol 30:681–685 (RS)

    Article  PubMed  CAS  Google Scholar 

  3. Mazzaferri EL, Robbins RJ, Spencer CA et al (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433–1441 (SR<RCT>)

    Article  PubMed  CAS  Google Scholar 

  4. Spencer CA, Takeuchi M, Kazarosyan M et al (1998) Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121–1127 (SR<RCT>)

    Article  PubMed  CAS  Google Scholar 

  5. Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142 (Others)

    Article  PubMed  Google Scholar 

  6. Heemstra KA, Liu YY, Stokkel M et al (2007) Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrinol 66:58–64 (RS)

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgery, Tokyo Medical University, Ibaraki Medical Center, 3-20-1 Chuo, Amimachi, Inashikigun, Ibaraki, 300-0395, Japan

    Minoru Fujimori

  2. Department of Breast and Endocrine Surgery, Clinical Science, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

    Hisato Hara

  3. Department of Thoracic and Thyroid Surgery, Tokyo Medical University, Tokyo, Japan

    Hidemitsu Tsutsui

Authors
  1. Minoru Fujimori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisato Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hidemitsu Tsutsui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minoru Fujimori .

Editor information

Editors and Affiliations

  1. Ito Hospital, 4-3-6 Jinguumae, Shibuya-ku, Tokyo, 150-8308, Japan

    Hiroshi Takami

  2. , Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe, 650-0011, Japan

    Yasuhiro Ito

  3. Noguchi Thyroid Clinic and Hospital Foun, 6-33 Noguchinaka-machi, Beppu, 874-0932, Japan

    Hitoshi Noguchi

  4. , Department of Breast and Endocrine Surge, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan

    Akira Yoshida

  5. , Department of Endocrine Surgery, Tokyo Women's Medical University, 8-1 Kawada- cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Takahiro Okamoto

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Japan

About this chapter

Cite this chapter

Fujimori, M., Hara, H., Tsutsui, H. (2013). CQ50. Is Serum Thyroglobulin Measurement Useful as a Marker of Carcinoma Recurrence After Surgery?. In: Takami, H., Ito, Y., Noguchi, H., Yoshida, A., Okamoto, T. (eds) Treatment of Thyroid Tumor. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54049-6_71

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54049-6_71

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54048-9

  • Online ISBN: 978-4-431-54049-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation